Based on our previous report that TLR4 bone marrow reconstitution had no impact on emphysema (Zhang et al., 2006) or survival during oxidant lung injury (Takyar et al., 2016), we focused on TLR4 reconstitution in structural cells rather than circulating cells. The gene discussed is TLR4; the disease is pulmonary emphysema.